Found: 4
Select item for more details and to access through your institution.
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response.
- Published in:
- Molecules, 2020, v. 25, n. 24, p. 6029, doi. 10.3390/molecules25246029
- By:
- Publication type:
- Article
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04209-8
- By:
- Publication type:
- Article
In vitro characterization of [<sup>125</sup>I] HY-3-24, a selective ligand for the dopamine D3 receptor.
- Published in:
- Frontiers in Neuroscience, 2024, p. 1, doi. 10.3389/fnins.2024.1380009
- By:
- Publication type:
- Article
PARP-1-targeted Auger emitters display high-LET cytotoxic properties in vitro but show limited therapeutic utility in solid tumor models of human neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.233965
- By:
- Publication type:
- Article